Osteoclast activation: Potent inhibition by the bisphosphonate alendronate through a nonresorptive mechanism

Journal of Cellular Physiology

Volumn 172, Issue 1, 1997, Pages 79-86

  Owens, Jane Marie ^a   Fuller, Karen ^a   Chambers, Timothy John ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALENDRONIC ACID; BISPHOSPHONIC ACID DERIVATIVE; COLONY STIMULATING FACTOR 1;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BONE MARROW CELL; CELL ACTIVATION; CELL DIFFERENTIATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG MECHANISM; MOUSE; NONHUMAN; OSTEOCLAST; OSTEOLYSIS; PRIORITY JOURNAL; RAT;

ACID PHOSPHATASE; ALENDRONATE; ANIMALS; ANIMALS, NEWBORN; CALCITRIOL; CELLS, CULTURED; MICE; OSTEOCLASTS; RATS; RATS, WISTAR; RECEPTORS, CALCITONIN;

ANIMALIA;

EID: 0030741078     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4652(199707)172:1<79::AID-JCP9>3.0.CO;2-A     Document Type: Article

References (54)

1. Asotra, S., Gupta, A.K., Sodek, J., Aubin, J.E., and Heersche, J.N.M. (1994) Carbonic anhydrase II mRNA expression in individual osteoclasts under "resorbing" and "nonresorbing" conditions. J. Bone Miner. Res., 9:1115-1122.
2. + independent and NEM sensitive. Am. J. Physiol., 257:C65-C76.
3. Burstone, M.S. (1958) Histochemical demonstration of acid phosphatases with naphthol AS-phosphate. J. Natl. Cancer Inst., 21:423-539.
4. Carano, A., Teitelbaum, S.L., Konsek, J.D., Schlesinger, P.H., and Blair, H.C. (1990) Bisphosphonates directly inhibit the bone resorption activity of isolated avian osteoclasts in vitro. J. Clin. Invest., 85:456-461.
5. Cecchini, M.G., and Fleisch, H. (1990) Bisphosphonates in vitro specifically inhibit, among the hematopoietic series, the development of the mouse mononuclear phagocyte lineage. J. Bone Miner. Res., 5:1019-1027.
6. Cecchini, M.G., Felix, R., Fleisch, H., and Cooper, P.H. (1987) Effect of bisphosphonates on proliferation and viability of mouse bone marrow-derived macrophages. J. Bone Miner. Res., 2:135-142.
7. Chambers, T.J., McSheehy, P.M.J., Thomson, B.M., and Fuller, K. (1985) The effect of calcium-regulating hormones and prostaglandins on bone resorption by osteoclasts disaggregated from neonatal rabbit bones. Endocrinology, 116:234-239.
8. Chow, J., Tobias, J.H., Colston, K.W., and Chambers, T.J. (1992) Estrogen maintains trabecular bone volume in rats not only by suppression of bone resorption but also by stimulation of bone formation. J. Clin. Invest., 89:74-78.
9. +-ATPase. J. Bone Miner. Res., 11:1498-1507.
10. Endo, N., Rutledge, S.J., Opas, E.E., Vogel, R., Rodan, G.A., and Schmidt, A. (1996) Human protein tyrosine phosphatase-σ alternative splicing and inhibition by bisphosphonates. J. Bone Miner. Res., 11:535-543.
11. 2MBP-coated bone. Bone Min., 6:33-43.
12. Flanagan, A.M., and Chambers, T.J. (1991) Inhibition of bone resorption by bisphosphonates: Interactions between bisphosphonates, osteoclasts, and bone. Calcif. Tissue Int., 49:407-415.
13. Fleisch, H. (1991) Bisphosphonates: Pharmacology and use in the treatment of tumor-induced hypercalcaemia and metastatic bone disease. Drugs, 42:919-944.
14. Fleisch, H., Russell, R.G.C., and Francis, M.D. (1969) Diphosphonates inhibit hydroxyapatite dissolution in vitro and bone resorption in tissue culture and in vivo. Science, 165:1262-1264.
15. Fuller, K., Owens, J.M., Jagger, C.J., Wilson, A., Moss, R., and Chambers, T.J. (1993) Macrophage colony-stimulating factor stimulates survival and chemotactic behavior in isolated osteoclasts. J. Exp. Med., 178:1733-1744.
16. Greenberger, J.S. (1984) Long-term hematopoietic cultures. In: Hematopoiesis. D.W. Golde, ed. Churchill Livingstone, New York, pp. 203-242.
17. Hughes, D.E., MacDonald, B.R., Russell, R.G.G., and Gowen, M. (1989) Inhibition of osteoclast-like cell formation by bisphosphonates in long-term cultures of human bone marrow. J. Clin. Invest., 83:1930-1935.
18. Hughes, D.E., Wright, K.R., Uy, H.L., Sasaki, A., Yoneda, T., Roodman, G.D., Mundy, G.R., and Boyce, B.F. (1995) Bisphosphonates promote apoptosis in murine osteoclasts in vitro and in vivo. J. Bone Miner. Res., 10:1478-1487.
19. Hunter, W.M., and Greenwood, F.C. (1962) Preparation of iodine 131 labelled human growth hormone of high specific activity. Nature, 194:495.
20. Jimi, E., Nakamura, I., Amano, H., Taguchi, Y., Tsurukai, T., Tamura, M., Takahashi, N., and Suda, T. (1996) Osteoclast function is activated by osteoblastic cells through a mechanism involving cell-to-cell contact. Endocrinology, 137:2187-2190.
21. Kanehisa, J., and Heersche, J.N.M. (1988) Osteoclastic bone resorption: In vitro analysis of the rate of resorption and migration of individual osteoclasts. Bone, 9:73-79.
22. Kanis, J.A. (1991) Drug used for treatment of Paget's disease. In: Pathophysiology and Treatment of Paget's Disease of Bone. J.A. Kanis, ed. Dunitz, London, pp. 159-216.
23. Lin, J.H. (1996) Bisphosphonates: A review of their pharmacokinetic properties. Bone, 18:75-85.
24. Lowik, C.W.G.M., Van der Pluyin, G., Van der Weel-Pals, L.J.A., Bloys van Treslong-de Groot, H., and Bijvoet, O.L.M. (1988) Migration and phenotypic transformation of osteoclast precursors into mature osteoclasts: The effect of a bisphosphonate. J. Bone Min. Res., 3:185-192.
25. Malgaroli, A., Meldolesi, J., Zambonin-Zallone, A., and Teti, A. (1989) Control of cytosolic free calcium in rat and chicken osteoclasts. J. Biol. Chem., 264:14342-14347.
26. McSheehy, P.M.J., and Chambers, T.J. (1986) Osteoblastic cells mediate osteoclastic responsiveness to parathyroid hormone. Endocrinology, 118:824-828.
27. Miller, S.C., and Jee, W.S.S. (1979) The effect of dichloromethylene diphosphonate, a pyrophosphate analog, on bone and bone cell structure in the growing rat. Anat. Rec., 193:439-462.
28. Mitlak, B.H., Finkelman, R.D., Hill, E.L., Li, J., Martin, B., Smith, T., D'Andrea, M., Antoniades, H.N., and Lynch, S.E. (1996) The effect of systemically administered PDGF-BB on the rodent skeleton. J. Bone Miner. Res., 11:238-247.
29. Mühlbauer, R.C., Bauss, F., Schenk, R., Janner, M., Bosis, E., Strein, K., and Fleisch, H. (1991) BM 21.0955, a potent new bisphosphonate to inhibit bone resorption. J. Bone Miner. Res., 6:1003-1011.
30. Murakami, H., Takahashi, N., Sasaki, T., Udagawa, N., Tanaka, S., Nakamura, I., Zhang, D., Barbier, A., and Suda, T. (1995) A possible mechanism of the specific action of bisphosphonates on osteoclasts: Tiludronate preferentially affects polarized osteoclasts having ruffled borders. Bone, 17:137-144.
31. Nicholson, G.C., Moseley, J.M., Sexton, P.M., Mendelsohn, F.A.O., and Martin, T.J. (1986) Abundant calcitonin receptors in isolated rat osteoclasts. J. Clin. Invest., 78:355-360.
32. Nishikawa, M., Akatsu, T., Katayama, Y., Yasutomo, Y., Kado, S., Kugai, N., Yamamoto, M., and Nagata, N. (1996) Bisphosphonates act on osteoblastic cells and inhibit osteoclast formation in mouse marrow cultures. Bone. 18:9-14.
33. Owens, J.M., Gallagher, A.C., and Chambers, T.J. (1996) Bone cells required for osteoclastic resorption but not for osteoclastic differentiation. Biochem. Biophys. Res. Commun., 222:225-229.
34. Papapoulos, S.E., Hoekman, K., Löwik, C.W.G.M., Vermeij, P., and Bijvoet, O.L.M. (1989) Application of an in vitro model and a clinical protocol in the assessment of the potency of a new bisphosphonate. J. Bone Miner. Res., 4:775-781.
35. Plasmans, C.M.T., Jap, P.H.K., Kuypers, W., and Sloof, T.J.J. (1980) Influence of a diphosphonate on the cellular aspect of young bone tissue. Calcif. Tissue Int., 32:247-256.
36. Ravesloot, J.H., Eisen, T., Baron, R., and Boron, W.F. (1995) Role of Na-H exchangers and vacuolar H pumps in intracellular pH regulation in neonatal rat osteoclasts. J. Gen. Physiol., 105:177-208.
37. Reginster, J.Y., Lecart, M.P., Deroisy, R., Sarlet, N., Denis, D., Ethgen, D., Collate, J., and Franchimont, P. (1989) Prevention of postmenopausal bone loss by tiludronate. Lancet, 2:1469-1471.
38. Rowe, D.J., and Hausmann, E. (1976) The alteration of osteoclast morphology by diphosphonates in bone organ culture. Calcif. Tissue Res., 20:53-60.
39. Sahni, M., Guenther, H.L., Fleisch, H., Collin, P., and Martin, T.J. (1993) Bisphosphonates act on rat bone resorption through the mediation of osteoblasts. J. Clin. Invest., 91:2004-2011.
40. Sato, M., Grasser, W., Endo, N., Akins, R., Simmons, H., Thompson, D.D., Golub, E., and Rodan, G.A. (1991) Bisphosphonate action. Alendronate localization in rat bone and effects on osteoclast ultrastructure. J. Clin. Invest., 88:2095-2105.
41. Sato, W., and Grasser, W. (1990) Effects of bisphosphonates on isolated rat osteoclasts as examined by reflected light microscopy. J. Bone Miner. Res., 5:31-40.
42. Schmidt, A., Rutledge, S.J., Endo, N., Opas, E.E., Tanaka, H., Wesolowski, G., Leu, C.T., Huang, Z., Ramachandaran, C., Rodan, S.B., and Rodan, G.A. (1996) Protein-tyrosine phosphatase activity regulates osteoclast formation and function: Inhibition by alendronate. Proc. Natl. Acad. Sci. USA, 93:3068-3073.
43. Selander, K., Lehenkari, P., and Väänänen, H.K. (1994) The effects of bisphosphonates on the resorption cycle of isolated osteoclasts. Calcif. Tissue Int., 55:368-375.
44. Shinoda, H., Adamek, G., Felix, R., Fleisch, H., Schenk, R., and Hagan, P. (1983) Structure-activity relationships of various bisphosphonates. Calcif. Tissue Int., 35:87-99.
45. Silver, I.A., Murrills, R.J., and Etherington, D.J. (1988) Microelectrode studies on the acid microenvironment beneath adherent macrophages and osteoclasts. Exp. Cell Res., 175:266-276.
46. Storm, T., Thamsborg, G., Steinichem, T., Genant, H.K., and Soerensen, O.H. (1990) Effect of intermittent cyclical etidronate therapy on bone mass and fracture rate in women with postmenopausal osteoporosis. N. Engl. J. Med., 322:1265-1271.
47. + -ATPase regulates cytoplasmic pH in murine macrophages. J. Biol. Chem., 265:7645-7654.
48. Tapper, H., and Sundler, R. (1992) Cytosolic pH regulation in mouse macrophages. Biochem. J., 281:245-250.
49. Teti, A., Grano, M., Colucci, S., Cantatore, F.P., Loperfido, M.C., and Zambonin-Zallone, A. (1991) Osteoblast-osteoclast relationships in bone resorption: Osteoblasts enhance osteoclast activity in a serum-free co-culture system. Biochem. Biophys. Res. Commun., 179:634-640.
50. Valkema, R., Vismans, F.-J.F.E., Papapoulos, S.E., Pauwels, E.K.J., and Bijvoet, O.L.M. (1989) Maintained improvement in calcium balance and bone mineral content in patients with osteoporosis treated with the bisphosphonate APD. Bone Miner., 5:183-192.
51. Vitté, C., Fleisch, H., and Guenther, H.L. (1996) Bisphosphonates induce osteoclasts to secrete an inhibitor of osteoclast-mediated resorption. Endocrinology, 137:2324-2333.
52. Watts, N.B., Harris, S.T., Genant, H.K., Wasnich, R.D., Miller, P.D., Jackson, R.D., Licata, A.A., Ross, P., Woodson, G.C., Yanover, M.J., Mysiw, W.J., Kohse, L., Rao, M.B., Steiger, P., Richmond, B., and Chesnut, C.H. (1990) Intermittent cyclical etidronate treatment of postmenopausal osteoporosis. N. Engl. J. Med., 323:73-79.
53. Wesoslowski, G., Duong, L.T., Lakkakorpi, P.T., Nagy, R.M., Tezuka, K.-I., Tanaka, H., Rodan, G.A., and Rodan, S.B. (1995) Isolation and characterization of highly enriched, prefusion mouse osteoclastic cells. Exp. Cell Res., 219:679-686.
54. Zimolo, Z., Wesolowski, G., and Rodan, G.A. (1995) Acid extrusion is induced by osteoclast attachment to bone. Inhibition by alendronate and calcitonin. J. Clin. Invest., 96:2277-2283.